Schizophrenia Drug Deaths Inconclusive, FDA SaysSchizophrenia Drug Deaths Inconclusive, FDA Says

An animal study suggests that much of the increase in olanzapine bloodstream levels occurred after — not before — the deaths of two patients in 2013. News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news